Using Circulating Tumor DNA to Personalize Duration of Consolidation Durvalumab

Clinical trial NCT05757843 · WITHDRAWN

Trial details

NCT number: NCT05757843
Sponsor: Indiana University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

NSCLC, Stage III

Start date: 2024-09-13
Primary completion: 2025-12-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.